Treatment change within 12 months of starting highly active antiretroviral therapy (HAART) in HIV-positive therapy-naive patients

被引：0
|
作者：
McNulty, M. [1 ]
Leighton, J. [1 ]
McFarlane, L. [1 ]
Ustianowski, A. [1 ]
机构：
[1] North Manchester Gen Hosp, Manchester, Lancs, England
来源：
HIV MEDICINE | 2013年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：59 / 59
页数：1
相关论文
共 50 条
  • [41] Infectious diarrhoea in antiretroviral therapy-naive HIV/AIDS patients in Kenya
    Wanyiri, Jane W.
    Kanyi, Henry
    Maina, Samuel
    Wang, David E.
    Ngugi, Paul
    O'Connor, Roberta
    Kamau, Timothy
    Waithera, Tabitha
    Kimani, Gachuhi
    Wamae, Claire N.
    Mwamburi, Mkaya
    Ward, Honorine D.
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2013, 107 (10) : 631 - 638
  • [42] Comparing costs and effectiveness of different starting points for highly active antiretroviral therapy in HIV-positive patients: Evidence from the ICONA cohort
    Merito M.
    Pezzotti P.
    The European Journal of Health Economics, 2006, 7 (1) : 30 - 36
  • [43] Measurement of thymus volume as a prognostic parameter in patients starting highly active antiretroviral therapy (HAART)
    Manfredi, R
    Battista, G
    Fiorini, K
    Canini, R
    Chiodo, F
    AIDS, 2000, 14 : S77 - S77
  • [44] Prevalence of resistance mutations associated with integrase inhibitors in therapy-naive HIV-positive patients in Hungary
    Ay, Eva
    Pocskay, Agnes
    Lakatos, Botond
    Szlavik, Janos
    Mezei, Maria
    Minarovits, Janos
    ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA, 2021, 68 (02) : 87 - 91
  • [45] Treatment Regimens for HIV Neurocognitive Dysfunctions in the Highly Active Antiretroviral Therapy (HAART) Era
    Burk Jubelt
    Current Neurology and Neuroscience Reports, 2010, 10 (6) : 417 - 419
  • [46] Reproductive-Organ Disease in HIV-Positive Nigerian Women: Does Highly Active Antiretroviral Therapy (HAART) Make a Difference?
    Agaba, P.
    Thacher, T.
    Ekwempu, C.
    Adisa, J.
    Agbaji, O.
    Idoko, J.
    Kanki, P.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2008, 12 : E202 - E202
  • [47] A stress and coping model of medication adherence and viral load in HIV-positive men and women on highly active antiretroviral therapy (HAART)
    Weaver, KE
    Llabre, MM
    Durán, RE
    Antoni, MH
    Ironson, G
    Penedo, FJ
    Schneiderman, N
    HEALTH PSYCHOLOGY, 2005, 24 (04) : 385 - 392
  • [48] Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients
    Monforte, AD
    Lepri, AC
    Rezza, G
    Pezzotti, P
    Antinori, A
    Phillips, AN
    Angarano, G
    Colangeli, V
    De Luca, A
    Ippolito, G
    Caggese, L
    Soscia, F
    Filice, G
    Gritti, F
    Narciso, P
    Tirelli, U
    Moroni, M
    AIDS, 2000, 14 (05) : 499 - 507
  • [49] Prevalence of hypertension in HIV-positive patients on highly active retroviral therapy (HAART) compared with HAART-naive and HIV-negative controls: Results from a Norwegian study of 721 patients
    Bergersen, BM
    Sandvik, L
    Dunlop, O
    Birkeland, K
    Bruun, JN
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2003, 22 (12) : 731 - 736
  • [50] Prevalence of Hypertension in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) Compared with HAART-Naive Patients at the Limbe Regional Hospital, Cameroon
    Dimala, Christian Akem
    Atashili, Julius
    Mbuagbaw, Josephine C.
    Wilfred, Akam
    Monekosso, Gottlieb L.
    PLOS ONE, 2016, 11 (02):
12345